perspektiven ???
sieht ganz interessant aus:
Calypte Up After China Approves HIV Test
NEW YORK (Reuters) - Shares of California biotech company Calypte Biomedical Corp. (CALY.O) more than doubled on Friday after the company announced late Thursday that China had approved its urine test for presence of antibodies to the HIV-1 strain of the virus that causes AIDS.
Calypte was up 2-5/8, or 175 percent, to 4-1/8, with over 10 million shares exchanging hands on the Nasdaq.
The company, which is based in Alameda, Calif., said after the market close on Thursday that the test would be the only urine-based HIV-1 test approved for distribution in China. It added that U.N. statistics show that an estimated half million Chinese are infected with the HIV virus. Reut10:38 08-25-00
weiß jemand mehr zu dieser company ?
danke
grüße
stiller teilhaber
sieht ganz interessant aus:
Calypte Up After China Approves HIV Test
NEW YORK (Reuters) - Shares of California biotech company Calypte Biomedical Corp. (CALY.O) more than doubled on Friday after the company announced late Thursday that China had approved its urine test for presence of antibodies to the HIV-1 strain of the virus that causes AIDS.
Calypte was up 2-5/8, or 175 percent, to 4-1/8, with over 10 million shares exchanging hands on the Nasdaq.
The company, which is based in Alameda, Calif., said after the market close on Thursday that the test would be the only urine-based HIV-1 test approved for distribution in China. It added that U.N. statistics show that an estimated half million Chinese are infected with the HIV virus. Reut10:38 08-25-00
weiß jemand mehr zu dieser company ?
danke
grüße
stiller teilhaber
